Infiltration of leukocytes is a hallmark of the inflammation process and is mediated by several chemotactic factors, one of which is interleukin (IL)-8. IL-8 has diverse biologic properties, including chemotaxis of neutrophils and T lymphocytes (1) , regulation of cell adhesion properties (2) , activation of neutrophils (3) , and modulation of histamine release (4, 5) . These observations implicate IL-8 as a key factor in the pathogenesis of inflammatory diseases. We previously demonstrated, both in vivo and in vitro , that IL-8 messenger RNA (mRNA) and protein in airway epithelial cells are increased in monkeys after ozone exposure (6) . This observation was also demonstrated in cultures of human airway epithelial cell (7) . The appearance of IL-8 in the airway lumen and surface epithelium is consistent with neutrophil influx in monkeys after ozone exposure (8) . Using IL-8-neutralizing antibody, we demonstrated an 80% inhibition of the chemotactic activity in conditioned media of ozone-exposed airway cultures. These observations suggest that an elevated IL-8 gene expression is an important step in regulating the migration and the activation of neutrophils in monkey airways after ozone exposure (6) .
IL-8 is regulated at both the transcriptional and posttranscriptional levels. The 3 Ј end of the IL-8 message contains the repetitive AUUUA unit, which is responsible for destabilization of a variety of cytokine mRNAs (9) . Within the 5 Ј -flanking region of the human IL-8 promoter are various motifs with potential for binding transcription factors activator protein (AP)-1, AP-2, AP-3, glucocorticoid receptor, nuclear factor (NF)-B, NF-IL-6, and octamer factor, etc. (10) . It has been suggested that the region spanning the nucleotides Ϫ 94 to Ϫ 70 relative to the transcription start site of the IL-8 gene is essential for both induction and repression by certain stimuli (11) (12) (13) (14) . This region contains the putative binding sites for NF-IL-6 and NF-B transcription factors. The binding of NF-B factors is indispensable for the activation of IL-8 gene transcription (11) . NF-IL-6 is required to attain maximal expression of the IL-8 gene. Several members of the NF-B family, such as p50 (NF-B1), p65 (RelA), c-Rel, and p52 (NF-B2), have been shown to bind the NF-B motif of the IL-8 promoter (12, 15, 16) . Inactive NF-B normally resides in the cytosol, anchored by an inhibitory molecule, I-B (17) . The major step in NF-B activation involves the dissociation of NF-B from I-B and its translocation to the nucleus (17) . However, the binding of NF-B to the B site in the nucleus is redox-regulated (18) . After the dissociation of I-B, reduction of NF-B protein is necessary for the binding of NF-B to its cis element (19) . Thioredoxin (TRX), a small multifunctional protein that has a redox-active disulfide/dithiol within the conserved active site sequence Cys-Gly-Pro-Cys, has been demonstrated as the agent necessary for reduction of NF-B (20) . Recently, it was shown that TRX protein can act as a potent costimulus of cytokine expression, including the IL-8 gene (21) .
To further understand the nature of IL-8 gene induction, the effects of culture conditions on IL-8 gene expression in airway epithelial cells were examined. We observed that the vitamin A derivative all-trans -retinoic acid (ATRA) used in the culture medium has profoundly enhanced IL-8 gene expression in vitro. This result is consistent with other reports in which different cell systems were used, including fibroblasts (22) , neuroblastoma cells (23), a human ovarian carcinoma cell line (24) , and a human melanoma cell line (15) . Studies have suggested an enhanced DNA-protein interaction on the NF-B site of IL-8 promoter region by ATRA through the enhanced synthesis of p50/p65 NF-B proteins (25) , or through the removal of the inhibitors that hindered the normal NF-B binding activity (15) . Despite these suggestions, the nature of ATRA-stimulated IL-8 gene expression is still not clear. In the present investigation, we demonstrate a novel mechanism that may be involved in the stimulation of IL-8 gene expression by ATRA. This mechanism involves activation of the NF-B transcriptional factor by TRX, whose expression is stimulated by vitamin A and its derivatives in airway epithelial cells (26) .
Materials and Methods

Sources of Tissues and Cell Culture Condition
Rhesus monkey airway tissues were obtained from the California Regional Primate Research Center, University of California at Davis. Human airway tissues were obtained from the autopsy lab or the organ transplant program of University of California Davis Medical Center. Procedures allowing the use of this excised organ for cell culture study were approved by a campus committee and are reviewed periodically.
Tracheobronchial epithelial (TBE) cells were isolated from monkey and human airway tissues and cultured on tissue culturegrade plastic dishes as described elsewhere (27, 28) . After 6 to 10 d incubation, when cultures were almost confluent, ATRA ranging from 0.1 nM to 1 M was added and the cultures were harvested 24 to 48 h later. An S (serum-sensitive) clonal line of BEAS-2B cells was also included in the study with culture conditions similar to those described earlier. BEAS-2B is an immortalized human bronchial epithelial cell line created through the transfection of a primary culture of human bronchial epithelial cells with simian virus 40 early-region gene (29) . The clonal line was kindly supplied by Dr. J. Lechner (Wayne State University, Detroit, MI).
Cycloheximide (CHX) (Sigma, St Louis, MO) was used to inhibit protein synthesis, and it was added at 10 g/ml, 30 min before ATRA treatment. Actinomycin D (Sigma) was used to inhibit new transcript synthesis, and it was added to the culture medium at 10 g/ml.
Quantitation of IL-8 by Enzyme-Linked Immunosorbent Assay
The level of IL-8 secretion was quantified by an enzyme-linked immunosorbent assay (ELISA) kit obtained from Biosource International (Camarillo, CA). The assayed value was normalized with the cell number in each dish. Triplicate dishes were used for each assay, and the assay was repeated at least three times in different primary and cell line cultures.
RNA Extraction and Northern Blotting Analysis
Total RNA was isolated by the single-step acid guanidium thiocyanate-phenol-chloroform extraction method as described elsewhere (30) . RNA Northern blot hybridization was carried out as described elsewhere (31) . Random primer labeling procedure was used to prepare [ 32 P]-labeled complementary DNA (cDNA) probes for hybridization. PG486, which is a PGEM 4Z-based clone (Promega, Madison, WI) containing a 486-base pair (bp) cDNA insert of the IL-8 coding region, was used as a template for cDNA probe preparation. The control cDNA probe for normalization of Northern blotting was a cDNA insert of 18S ribosomal RNA (rRNA), as described elsewhere (26) .
Nuclear Run-On Assay
Nuclear run-on assay was performed according to the method of Greenberg and Ziff (32) with some modification (33) . Duplicate slot membranes containing equal amounts of IL-8 (5 g), small proline-rich protein (SPRR1) (33) (5 g), and glyceraldehyde-3-phosphate dehydrogenase (GAP DH) cDNA inserts (0.5 g) were prepared and used for hybridization. Equal radioactive counts of [ 32 P]RNA from each sample were used to hybridize the cDNA slot membranes using the same conditions as the Northern blot analysis.
Construction of the Chloramphenicol Acetyltransferase Expression Vector
DNA fragment corresponding to the 5 Ј -flanking region of the human IL-8 gene (from ϩ 19 to Ϫ 1,472) was obtained by polymerase chain reaction (PCR) with appropriate primers based on the published sequence (15) . Using this fragment as the template, six different sizes of DNA fragments corresponding to the 5 Ј -flanking region were generated. These DNA fragments were then subcloned into pBL-CAT3 vector (34) at the restriction sites Bgl II and Hin dIII to place the IL-8 promoter region upstream of the reporter gene, chloramphenicol acetyltransferase (CAT). The resulting clones were named pc 65 (from ϩ 19 to Ϫ 65), pc 165 ( ϩ 19 to Ϫ 165), etc. For construction of the DNA fragment encoding three point mutations at the NF-B binding site of the promoter gene, a PCR-based mutagenesis technique was used as described elsewhere (34) . Briefly, each external primer and one of two internal mutated primers were used first to generate two partial and overlapping DNA fragments, then these two external primers were used to PCR-amplify the entire region for subsequent cloning. DNA sequencing was used to verify the sequences of all these chimeric construct clones.
DNA Transfection and CAT Assay
BEAS-2B (S clone) cells were transfected with these IL-8 promoter-CAT chimeric constructs by a liposome (GIBCO BRL, Grand Island, NY)-mediated method as described elsewhere (34) . Briefly, cultures at around 60% confluency were transfected with a premixed DNA and liposome preparation in serum-and antibiotic-free F12 nutrient. After overnight incubation, the medium was replaced by the normal hormone-supplemented medium. ATRA was added to some of these cultures. Retinoic acid nuclear receptor-␣ (RAR-␣ ) expression clone, kindly provided by Dr. R. Evans' lab (The Salk Institute, La Jolla, CA), was included for cotransfection as needed. After an additional 48 h incubation, cell extracts from these cultures were prepared for CAT assay. The CAT ELISA kit from Boehringer Mannheim (Indianapolis, IN) was used to determine the CAT activity. The ␤ -galactosidase ( ␤ -gal) activity of psv-␤ -gal (Promega)-transfected cells was used as an internal control for the normalization of transfection efficiency.
Nuclear Extract Preparation
Confluent cultures of primary human TBE cells, monkey TBE cells, or the BEAS-2B S clone cell line were used for nuclear extract preparation with the method described by Kunsch and Rosen (16) . Binding reactions were carried out in a 20-l binding reaction mixture consisting of 25 mM N -2-hydroxyethylpiperazine-N Ј -ethane sulfonic acid (pH 7.9), 50 mM NaCl, 5 mM MgCl 2 , 0.5 mM ethylenediaminetetraacetic acid (EDTA), 5% glycerol, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 1 mg of bovine serum albumin (BSA) per ml, 0.1 g of poly d(I-C), and 10 g of nuclear extract. The mixture was then incubated at room temperature for 20 min with 1 ng of [ 32 P]-labeled oligonucleotide probe. For the competition assay, unlabeled cNF-B, IL-8-NF-B, IL-8 Ϫ 88/ Ϫ 67, and cNF-B m DNA were each added at 3-, 30-, and 100-fold excess. In the supershift experiments, anti-p50 and anti-p65 antibodies (Santa Cruz Biotech) were added to the binding reaction mixtures, and the mixtures were incubated for 1 h at 4 Њ C before adding the oligonucleotide probe. After 30 min, the samples were loaded onto 4% native polyacrylamide gels with 0.5 ϫ Tris borate-EDTA electrophoresis buffer. After electrophoresis, gels were dried and autoradiographed.
Electrophoretic Mobility Shift Assay
Western Blot Analysis
Protein of nuclear extracts prepared from airway epithelial cells grown with or without ATRA was electrophoretically separated on sodium dodecyl sulfate (SDS)-polyacrylamide gels and blotted onto nitrocellulose paper as described by Towbin and colleagues (35) . Anti-p50 and anti-p65 antibodies (Santa Cruz Biotech) were used as the primary antibody and an ABC kit (Vector Laboratory, Burlingame, CA) was used for the second antibody and the color reaction.
Results
IL-8 Gene Expression Is Enhanced by ATRA
ATRA dose-dependent stimulation of IL-8 secretion is demonstrated in various airway epithelial cultures (Figure 1 ). For primary human TBE cells, IL-8 protein increased from 3.5 ng/10 6 cells/h in the absence of ATRA to 11.5 ng/10 6 cells/h after 1 M ATRA treatment. For monkey TBE cells a similar trend was observed, although IL-8 secretion was lower (1 ng/10 6 cells/h increased to 8 ng/10 6 cells/h). Compared with primary cells, IL-8 secretion was one order of magnitude less in the immortalized TBE cell line; however, the effect of ATRA was the same. Overall, ATRA treatments stimulated the IL-8 secretion 3-to 8-fold.
We observed a similar dose-dependent increase of steadystate IL-8 mRNA levels after ATRA exposure ( Figure 2 ). After normalization with 18S ribosomal probe hybridization, this increase ranged from 3-to 4-fold in primary human TBE cells ( Figure 2A ) and BEAS-2B cells ( Figure 2C ), up to 8-fold in primary monkey TBE culture ( Figure 2B ).
As shown in Figure 3 , enhanced IL-8 message in primary human TBE cells ( Figure 3A) and BEAS-2B cell line ( Figure 3C ) was seen 12 h after ATRA treatment. For monkey TBE cells, maximal stimulation was not observed until 48 h after ATRA treatment, whereas in human TBE cells a plateau was reached 24 h after treatment.
New Protein Synthesis Is Required for ATRA Stimulation CHX, a protein synthesis inhibitor, was used to treat cultures before ATRA treatment. As shown in Figure 4 , ATRA stimulated IL-8 mRNA in the absence of CHX. In the presence of CHX the ATRA-mediated enhancement of IL-8 no longer exists. When CHX was added to cells, there was a superinduction of IL-8 mRNA under both ϩATRA and ϪATRA conditions. This superinduction may have obscured the ATRA-mediated enhancement. However, the degree of superinduction was similar for both ϩATRA and ϪATRA conditions. These results suggest that new protein synthesis is required for ATRA to elevate IL-8 message.
ATRA Regulates the IL-8 Message at the Transcriptional Level
To distinguish between transcriptional and post-transcriptional regulation, actinomycin D (which inhibits new transcript synthesis) was used to determine the half-life of IL-8 mRNA of the cultured cells. As shown in Figure 5 , IL-8 message has a half-life close to 50 min, and ATRA treatment had no obvious effect on the half-life of IL-8 mRNA.
In contrast to the results of the actinomycin D experiment, nuclear run-on assay demonstrated that more IL-8 transcripts were transcribed in the nucleus in ATRAtreated human TBE cultures than in ATRA-free human TBE cultures ( Figure 6 ). New transcript synthesis of the control genes SPRR1 and GAPDH was not affected by ATRA. Therefore, at least a part of ATRA-mediated IL-8 message enhancement occurs at the transcriptional level.
Characterization of ATRA-Mediated Transcriptional Regulation of IL-8 Gene
Two approaches were used to elucidate transcriptional regulation of the IL-8 gene by ATRA. One was the promoter-reporter gene transfection approach; the other was to measure the DNA-protein-binding activity by electrophoretic mobil- ity shift assay (EMSA). To elucidate the 5Ј-flanking region responsible for the promoter activity of the IL-8 gene, various chimeric constructs were prepared as described in MA-TERIALS AND METHODS. As shown in Figure 7 , the relative CAT activity was enhanced in cultures treated with ATRA. Due to the presence of negative cis-element in addition to the positive element in the chimeric construct with 5Ј-flanking region longer than 200 bp, the CAT activity decreased when the size of IL-8 promoter in the construct was increased. However, the ATRA-mediated enhancement of CAT activity seemed to be independent of the length of the IL-8 promoter, as long as the two essential motifs, NF-IL-6 and NF-B binding sites, were included. Cotransfection with RAR-␣ expression clone greatly increased ATRA-mediated enhancement of IL-8 promoter-dependent CAT activity, whereas RAR-␣ cotransfection without ATRA made no significant difference. Further, a mutation at the NF-B binding site abrogated not only the ATRA and RAR-␣ responses but also the basal promoter activity of IL-8. These results suggest that ATRA-response and RAR-␣-responsive cis elements are present within the region of nucleotide -165 to ϩ19 relative to the transcription start site of the IL-8 gene, and this region contains the NF-B binding site.
To investigate whether ATRA treatment affects NF-B binding activity, double-stranded DNA fragments corresponding to the cNF-B sequence and the NF-B binding sequence of IL-8 gene (IL-8-NF-B) were used to react the nuclear extracts prepared from cultures treated with or without ATRA. As shown in Figure 8A , when reacted with [ 32 P]-labeled cNF-B, nuclear extracts prepared from ATRA-untreated and -treated cells ( Figure 8A lanes 1 and  2) caused two retarded bands: "a" and "b." Band "b" is much stronger in the ATRA-treated than in the untreated preparation. The specificity of the binding was supported by cold DNA competition when bands "a" and "b" disappeared due to the addition of unlabeled IL-8-NF-B, IL-8 Ϫ88/Ϫ67 DNA fragments ( Figure 8A ) or cNF-B DNA itself ( Figure 8C ). This competition was not observed with the addition of unlabeled cNF-B m that had a mutation on the B binding site ( Figure 8B ). The specificity of the binding was further supported by the supershift phenomenon when the binding complex was treated with antibodies specific to the subunit proteins of NF-B transcriptional factors p50 and p65. Treatment of the binding complex with anti-p50 caused the supershift of the binding complexes (from "a" to "c" and "b" to "d"). Treatment with anti-p65 caused a disappearance of "b" and the formation of "d." Anti-p65 treatment also increased the binding activity at the "a" band. When a [ 32 P]-labeled IL-8-NF-B DNA fragment was used as probe ( Figure 8C ), the binding pattern was slightly different from Figures 8A and 8B. An additional nonspecific band was seen, which was probably due to the difference of a few nucleotides between the cNF-B oligomer and the IL-8-NF-B oligomer. However, ATRAmediated enhancement of NF-B binding is still very clear, and is especially noticeable in band "b." Both bands "a" and "b" could be completely abolished by unlabeled cNF-B DNA, suggesting that the binding in these complexes is very specific. These results demonstrate that ATRA treatment enhances the retardation of both consensus NF-B and IL-8-specific NF-B sequences by EMSA.
The Protein Amount of NF-B Subunits in the Nucleus
Is Not Affected by ATRA Western blot analysis was used to identify and quantify the amount of p50 and p65 subunits of NF-B protein in the nucleus. A total of 1 g/ml of anti-p50 or anti-p65 antibodies was added to a nitrocellulose membrane that contained the nuclear extracts of ATRA-treated and untreated human TBE cells. The resulting data show that the intensity of the bands remained the same regardless of the addition or the absence of ATRA in the human TBE cells (Figure 9 ).
Effects of TRX on ATRA-Enhanced IL-8 Gene Expression
Because new protein synthesis is required for ATRAdependent IL-8 gene expression as described earlier, we looked into the functional role of genes that are enhanced or induced early by ATRA in IL-8 gene expression. We have previously demonstrated that induced TRX gene expression was one of the early events induced by ATRA. As described in our previous publication (26) , TRX message was elevated within 4 h after retinol treatment. In addition, it has been recognized that TRX plays an important role in the regulation of various transcriptional factors, including NF-B (19, 20) , and that TRX protein can act as a potent costimulus of cytokine expression (21) . Inasmuch as there is Figure 9 . Amounts of NF-B protein subunits p50 and p65 in the nucleus were determined by Western blot analysis. Equal amounts (20 g) of nuclear extracts from ATRAtreated and untreated human TBE cells were separated on an SDS polyacrylamide gel. The material on the gel was then transferred to nitrocellulose membrane and allowed to react with 1 g/ml anti-p50 or anti-p65 antibodies. The intensity of the resulting bands represents the protein amount of p50 and p65 in those nuclear extracts. The same results were observed in three separate experiments.
no ATRA-responsive element in the IL-8 Ϫ165/ϩ19 region, it is possible that a part of ATRA's effect on IL-8 gene expression may be due to an enhanced synthesis of TRX by ATRA. For these reasons we sought to determine whether TRX protein is able to activate the binding activity of NF-B protein in our TBE cells. As shown in Figure 10 , TRX treatment was able to elevate the NF-B binding activity in a dose-responsive manner, especially the "b" complex. The supershift experiments with anti-p65 antibody further support the notion that the "b" DNA-protein complex is elevated by TRX protein. Transfection studies were used to determine whether TRX protein could further stimulate the IL-8 promoter activity. As shown in Figure 11 , when IL-8 pc165-transfected cells were treated with TRX protein, the relative CAT activity was elevated 3-fold as compared with the control. In contrast, when the NF-B binding site of IL-8 promoter was mutated, TRX-stimulated CAT activity was not observed. These results further support the notion that a part of ATRA's effects on IL-8 gene expression may occur through enhanced TRX gene expression.
Discussion
We report here that ATRA can enhance IL-8 gene expression 3-to 8-fold in cultures of various airway epithelial cells, including primary TBE cells derived from human and nonhuman primate tissues. The enhancement is timeand dose-dependent. Both the time course and CHX treatment experiments suggest the involvement of a delayed and, perhaps, an indirect mechanism requiring new protein synthesis for ATRA-mediated stimulation of the IL-8 gene. ATRA has no significant effect on the IL-8 mRNA stability, a conclusion based on the actinomycin D treatment experiment in which a half-life of around 50 min for IL-8 message was observed in cultures with or without ATRA. The nuclear run-on assay demonstrated that ATRA increases the transcription rate of the IL-8 gene. This transcriptional regulation by ATRA is further supported by the transient transfection study with the promoter-reporter construct. The cotransfection experiment with RAR-␣ in the transient transfection study also demonstrated a further requirement for the interaction between ATRA and its receptor to maximize CAT reporter gene activity. This is consistent with an ATRA-dependent transcriptional regulation.
The second observation obtained from this study is the finding that ATRA-dependent transcriptional regulation is related to activation of DNA-protein interaction on the NF-B motif of the IL-8 promoter region. This conclusion is based on deletion and site-directed mutagenesis analyses with transient transfection studies, as well as results of EMSA studies. The deletion analysis of various 5Ј-flanking regions of the IL-8 gene has demonstrated that the stimulation of CAT activity by ATRA during transient transfection depends on the presence of the NF-B motif in the promoter-reporter construct. EMSA assays further demonstrated that NF-B binding activity in nuclear extract is increased by ATRA treatment. This binding can be completely replaced by the DNA fragment of the IL-8 promoter region from nucleotides Ϫ67 to Ϫ88, on the basis of competition assays. This region contains consensus DNA sequences corresponding to binding sites for NF-B transcriptional factors (12, 36) , which has been implicated in regulating IL-8 gene expression in various cell systems. The supershift patterns with various antibodies specific for NF-B subunits indicate that this ATRA-enhanced NF-B binding involves the participation of p50 and p65 subunits (Figure 8 ). For p50, at least two DNA-protein complexes were observed, "a" and "b" bands. For the p65 subunit, only the "b" band was involved. More importantly, ATRA specifically enhances the "b" band and has little effect on the "a" complex, indicating that ATRA treatment is more specific for the activation of p65-related complex. Further, the amounts of p50 and p65 in the nuclei did not change after the addition of retinoic acid, as demonstrated in the Western blot assay. This indicates that the availability of Figure 10 . Effects of recombinant human TRX protein on NF-B binding activity as assayed by EMSA. Nuclear extracts from ATRA-free primary monkey TBE cells were used in this study, and the preparation of nuclear extract was carried out as described in MATERIALS AND METHODS. The EMSA conditions were as described in Figure 8 . both p50 and p65 in the nuclei is the same regardless of the presence or absence of ATRA.
Activation of NF-B binding activity by ATRA, however, cannot explain how ATRA is involved in the transcriptional activation of the IL-8 gene. Normally, retinoic acid exerts its effect through binding to nuclear receptors, namely, the retinoic acid receptors (RAR-␣, -␤, -␥) and the retinoid X receptors (RXR-␣, -␤, -␥) (37) (38) (39) (40) (41) (42) . RARs usually form heterodimers with RXRs (43), and these dimers are able to bind to specific DNA sequences, known as retinoic acid-responsive elements (RARE). They act as ligand-inducible transcription factors. The consensus sequence of RARE contains hexanucleotide half-sites arranged as inverted or direct repeats spaced by various numbers of nucleotides (44, 45) . Even though the IL-8 gene does not contain the classical ATRA response elements, ATRA has been shown to upregulate IL-8 expression in several cell types, including fibroblasts (22) , neuroblastoma cells (23) , a human ovarian carcinoma cell line (24) , and a human melanoma cell line (15) . The exact mechanism by which ATRA regulates this expression is still not clear. Activation of cells by appropriate stimuli results in the dissociation of I-B from NF-B and the translocation of NF-B to the nucleus (46, 47) . It is possible that ATRA may either enhance the synthesis of NF-B subunit proteins (25) or suppress the level of I-B, an inhibitor of NF-B nuclear translocation. However, the amounts of both p50 and p65 in the nuclei remained the same regardless of the presence or absence of retinoic acid, as demonstrated by Western blot assays ( Figure 9 ). This implies that the addition of ATRA to cells does not increase the amount of NF-B protein in the nuclei through the removal of I-B (48, 49). Harant and associates (15) have demonstrated in tumor necrosis factor-␣-stimulated A3 cells an ATRA-induced disappearance of two additional DNA-protein bands, in EMSA assays. They postulated that these bands play an inhibitory role in the regulation of NF-B binding. However, we did not see two such additional bands in TBE cells.
Several groups (18) (19) (20) 50) have demonstrated the importance of redox regulation on the activation of NF-B (19) . They have shown that NF-B reduction in the nucleus represents a necessary step for NF-B-DNA binding activity. Matthews and coworkers (20) further demonstrated that TRX increases the binding of NF-B to DNA by reduction of a disulfide bond involving cysteine 62. Schenk and colleagues (21) have demonstrated that recombinant human TRX protein is a costimulus of cytokine gene expression, including the IL-8 gene. We have previously demonstrated that retinol and its derivatives, retinoids, are potent stimulators for TRX gene expression in airway epithelium (26) . To determine whether TRX is involved in ATRA-dependent IL-8 gene expression, we demonstrated that purified human TRX protein is able to elevate NF-B activity (Figure 10 TRX has been found in various cellular compartments, including the extracellular medium (21, (51) (52) (53) (54) . It has been suggested that TRX protein can go through a leaderless pathway to be translocated from the cytosol to the plasma membrane without the help of intracellular vesicles (53, 54) . The nature of the transport is still not completely known. We think that a similar mechanism of transport from media to nucleus may exist when recombinant TRX protein is added to the culture medium. In a separate study, we observed the presence of FLAG antigen in the nucleus after treating cells exogenously with purified FLAG-TRX fusion protein (Harper and colleagues, manuscript in preparation). This result will support the notion that the recombinant human TRX protein is able to transport to the nucleus to exert its redox action on NF-B transcription factor. Taking these data together, we propose an alternative mechanism in which ATRA elevates IL-8 gene transcription possibly through enhanced TRX protein synthesis. Experiments are currently underway in our laboratory to determine whether antisense or dominant negative approaches to TRX gene expression can modulate ATRAdependent IL-8 gene expression in airway epithelium.
In summary, we have demonstrated that ATRA has stimulatory effects on IL-8 gene expression in various airway epithelial cultures. The stimulation is related to activation of NF-B binding activity, which is essential for enhanced IL-8 gene expression. However, there is no evidence to support a direct interaction between ATRA-mediated transcriptional machinery and the IL-8 gene transcription. We offer instead an alternative mechanism whereby ATRA stimulates TRX protein synthesis, which then activates the IL-8 gene transcriptional complex.
